No abstract available
MeSH terms
-
Animals
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Clinical Trials as Topic
-
Disease Progression
-
Disease-Free Survival
-
Erlotinib Hydrochloride
-
Humans
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / pathology
-
Prognosis
-
Protein Kinase Inhibitors / therapeutic use*
-
Quinazolines / therapeutic use*
-
Research Design
-
Vascular Endothelial Growth Factor A / metabolism
Substances
-
Protein Kinase Inhibitors
-
Quinazolines
-
Vascular Endothelial Growth Factor A
-
Erlotinib Hydrochloride